| Appointed Soohyun Lew, with 30 years of Rich Experience and Expertise, as Vice President
| Expected to Contribute to Top-Level Strategic Development in Clinical Trials and Global Business Expansion
JNPMEDI, now advancing as a leading RDC company in life sciences, announced on the 10th the recruitment of Vice President Soohyun Lew, renowned for his broad experience and expertise, to lead Seoul CRO and DreamCIS.
Vice President Soohyun Lew, a specialist in family medicine at Yonsei University College of Medicine and certified in clinical pharmacology, brings over 30 years of experience. He has held positions as CEO of Seoul CRO, DreamCIS, and served as Medical Director at GE Healthcare and Novartis, accumulating extensive experience and expertise in top-level strategic development and global commercialization within the industry.
Additionally, Vice President Lew has been active as a global CT advisory board member for KoNECT and a member of the MFDS ICH advisory committee, contributing to global clinical trial consultation, international regulatory harmonization, pharmaceutical regulatory development, BD networking expansion, medical consulting, and other areas in clinical and medical fields.
Through the appointment of Vice President Lew, JNPMEDI aims to strengthen its strategic development in clinical trials, pharmaceuticals, and medical devices, enhancing expertise in global business.
A JNPMEDI spokesperson stated, "We look forward to leveraging Vice President Soohyun Lew's outstanding leadership, expertise, and international network to develop optimal strategies, lead global standards, and deliver maximum value to our customers.
| Appointed Soohyun Lew, with 30 years of Rich Experience and Expertise, as Vice President
| Expected to Contribute to Top-Level Strategic Development in Clinical Trials and Global Business Expansion
JNPMEDI, now advancing as a leading RDC company in life sciences, announced on the 10th the recruitment of Vice President Soohyun Lew, renowned for his broad experience and expertise, to lead Seoul CRO and DreamCIS.
Vice President Soohyun Lew, a specialist in family medicine at Yonsei University College of Medicine and certified in clinical pharmacology, brings over 30 years of experience. He has held positions as CEO of Seoul CRO, DreamCIS, and served as Medical Director at GE Healthcare and Novartis, accumulating extensive experience and expertise in top-level strategic development and global commercialization within the industry.
Additionally, Vice President Lew has been active as a global CT advisory board member for KoNECT and a member of the MFDS ICH advisory committee, contributing to global clinical trial consultation, international regulatory harmonization, pharmaceutical regulatory development, BD networking expansion, medical consulting, and other areas in clinical and medical fields.
Through the appointment of Vice President Lew, JNPMEDI aims to strengthen its strategic development in clinical trials, pharmaceuticals, and medical devices, enhancing expertise in global business.
A JNPMEDI spokesperson stated, "We look forward to leveraging Vice President Soohyun Lew's outstanding leadership, expertise, and international network to develop optimal strategies, lead global standards, and deliver maximum value to our customers.